5 completed, 1 not yet recruiting. 3 Phase 1, 2 Phase 3.
By phase and status
Follow Darunavir (DRV): new trials by email Literature Review of Darunavir (DRV) trials Research Report on Darunavir (DRV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix .
Trial Phase Status Sponsor Enrollment Start Updated
An Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in Children and Adolescents With HIV in Africa Dolutegravir (DTG), Abacavir (ABC), Lamivudine (3TC) - HIV Infection Phase 3 Not yet recruiting 800 2026-11-01 2026-08-28 Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult Participants Darunavir (DRV), Cobicistat (COBI), Emtricitabine (FTC) - Healthy Phase 1 Completed 30 2016-12-01 2025-02-03 DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV) BMS-663068, Darunavir (DRV), Ritonavir (RTV) - Infection, Human Immunodeficiency Virus Phase 1 Completed 42 2014-02-01 2017-08-08 TMC114-TiDP3-C176 - A Study in Healthy Volunteers Investigating the Bioequivalence Between Two Commercially Available 400-mg Tablets to One New 800-mg Tablet of Darunavir (DRV) in the Presence of Low-dose Ritonavir Under Fed and Fasted Conditions Darunavir (DRV), ritonavir - Healthy Phase 1 Completed 128 2011-01-01 2014-02-06 A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN) Darunavir (DRV), Ritonavir (rtv) - Human Immunodeficiency Virus - Type 1 Phase 3 Completed 590 2007-10-01 2013-02-15 IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults Raltegravir (RAL), Atazanavir (ATV), Ritonavir (RTV) - HIV Infections Completed 168 2002-08-01 2015-08-07
Conditions studied Acquired Immunodeficiency Syndrome (2) · HIV Infections (2) · Infections (1)
Sponsors Tibotec Pharmaceuticals, Ireland (2) · International Maternal Pediatric Adolescent AIDS Clinical Trials Group (1) · Janssen Scientific Affairs, LLC (1) · University College, London (1) · ViiV Healthcare (1)
Countries United States (3) · Germany (2) · Puerto Rico (2) · Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Chile (1) · France (1) · Guatemala (1) · Hungary (1) · Malaysia (1) · Panama (1) · Romania (1) · South Africa (1)
Top investigators Jennifer R. King, PharmD (1) · Ram Yogev, MD (1)
Results publications PMID 23558157 , PMID 25109510 , PMID 27583590 , PMID 35315687
NIH funding U01AI068632 (1)